The Latest Breaking News from Pfizer

Babies and children under five to be offered Covid jab for the first time

The JCVI has advised that clinically vulnerable children aged six months to four years should be offered the vaccincation.

The Independent UK · Apr 6, 2023

Covid vaccine to be offered to vulnerable babies and children in UK

Eligible children between six months and four years old will be offered jab from June

The Guardian - UK · Apr 6, 2023

Ursula von der Leyen: EU’s ‘general’ nears endgame of turbulent first term

European Commission president is praised for work ethic and response to Covid and Ukraine war, but some see her as aloof

The Guardian - UK · Apr 5, 2023

Spring Covid booster campaign gets under way next week

Millions of people will be sent their initial invitations through the NHS app, where they can also book their appointment.

The Independent UK · Mar 31, 2023

TGA weighs up RSV vaccine for older Australians

A vaccine for the potentially deadly respiratory syncytial virus (RSV) is being assessed by the TGA for use by people aged over 60.

The New Daily · Mar 29, 2023

I Finally Caught COVID. The Government Made the Experience Even Worse.

Thanks to onerous regulations, life-saving drugs are more expensive and harder to get.

Reason · Mar 29, 2023

Pfizer's chief corporate affairs officer remembers the moment she figured out how to 'break through' to skeptical consumers during COVID

Sally Susman is the author of "Breaking Through: Communicating to Open Minds, Move Hearts, and Change the World."

Fortune · Mar 28, 2023

Chinese Foreign Minister Qin Gang assures US business leaders of Beijing's support

China remains committed to a "healthy, stable and constructive" relationship with the US amid still "chilly" bilateral ties, Chinese Foreign Minister Qin Gang told visiting American business leaders on Saturday.

Bangkok Post · Mar 26, 2023

Michael Hiltzik: Biden says he wants to bring down drug prices. His actions tell a different story

You might get the impression from the Biden administration's insulin price cut and its initiative allowing Medicare to negotiate over other pharmaceuticals that the drug pricing issue is finally being taken seriously in Washington.

Los Angeles Times · Mar 24, 2023

The Best Defensive Stocks to Buy in an Uncertain Market

If you're concerned about war, inflation, interest rates and economic growth, the best defensive stocks can help protect your portfolio.

Kiplinger · Mar 24, 2023